Larry Dillaha
Directeur Technique/Scientifique/R&D chez NUTRIBAND INC.
Postes actifs de Larry Dillaha
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NUTRIBAND INC. | Directeur Technique/Scientifique/R&D | 02/08/2018 | - |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Directeur des opérations | - | - |
| Directeur Technique/Scientifique/R&D | - | - | |
Melt Pharmaceuticals, Inc.
 Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Directeur/Membre du Conseil | 01/06/2021 | - |
| Directeur Général | 01/06/2021 | - |
Historique de carrière de Larry Dillaha
Anciens postes connus de Larry Dillaha
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| HARROW, INC. | Directeur Technique/Scientifique/R&D | - | 01/01/2021 |
| REPROS THERAPEUTICS INC | Directeur/Membre du Conseil | 10/04/2017 | 01/02/2018 |
| Directeur Général | 01/02/2017 | 01/02/2018 | |
| President | 01/02/2017 | 01/02/2018 | |
Cavtherx, Inc.
 Cavtherx, Inc. Miscellaneous Commercial ServicesCommercial Services Cavtherx, Inc. provides biological research services. The private company is based in New Haven. | Directeur/Membre du Conseil | 01/06/2016 | 01/02/2017 |
| Directeur Général | 01/06/2016 | 01/02/2017 | |
| INSYS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 11/05/2011 | 11/05/2014 |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Directeur Technique/Scientifique/R&D | 01/03/2006 | 01/03/2010 |
| SHIONOGI & CO., LTD. | Directeur Technique/Scientifique/R&D | 01/04/2006 | - |
| ░░░░░░░░░░░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Larry Dillaha
| University of Tennessee | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 13 |
| Japon | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 8 |
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
Sectorielle
| Health Technology | 11 |
| Health Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SHIONOGI & CO., LTD. | Health Technology |
| NUTRIBAND INC. | Health Technology |
| HARROW, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Baptist Hospital (Tennessee)
 Baptist Hospital (Tennessee) Hospital/Nursing ManagementHealth Services Baptist Hospital (Tennessee) provides healthcare services. The company offers services in the areas of cancer, cardiac, and diabetes. Its services include rehabilitation and childbirth services. Baptist Hospital was founded in 1918 and is headquartered in Nashville, TN. | Health Services |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Cavtherx, Inc.
Cavtherx, Inc. Miscellaneous Commercial ServicesCommercial Services Cavtherx, Inc. provides biological research services. The private company is based in New Haven. | Commercial Services |
Shionogi Pharma, Inc.
Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
| Sanofi-Synthelabo, Inc. | Health Technology |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Health Technology |
- Bourse
- Insiders
- Larry Dillaha
- Expérience